Barely Significant
← all excerpts

Development of a multi-epitope vaccine against Helicobacter pylori using a novel saRNA technology through an immunoinformatics approach.

Sci Rep · 2025 · PMC12484783 · PMID 41028278

1
hedged sentence
closest p
boldest claim

The sentences

showed a trendno p-value reported
The predicted normalized B-factor for the target protein showed a trend consistent with the expected B-factor profile (Fig. 7 C), reinforcing the reliability of the model and providing valuable insights into the protein’s thermal mobility and flexibility.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.